NMN

Is NMN safe?

In the short term, it looks safe for healthy adults. Nicotinamide mononucleotide (NMN) is a small molecule the body makes from vitamin B3 and turns into NAD+, a coenzyme every cell needs. A 2026 meta-analysis in Nutrients pooled randomised trials using 250 to 2,000 mg a day for 14 days to 24 weeks and found no rise in adverse events or liver enzymes. The European Food Safety Authority (EFSA) concluded in 2026 that up to 300 mg a day is safe for adults.

Two things hold the score back. Nobody has tested NMN for years in large groups, which is how it is often marketed. And independent tests have found products with far less NMN than the label claims, or none at all.

What do the trials show?

The safety picture is reassuring but short. The 2026 meta-analysis found 15 randomised trials, 10 of which reported safety data. Overall adverse events, serious events, withdrawals and liver tests (ALT and AST) were no different from placebo.

On benefits, the same review found no effect on body weight, fasting glucose, HbA1c, cholesterol or systolic blood pressure, and only a small fall in diastolic pressure. NMN reliably raises NAD+ in blood. Whether that slows ageing in people is unproven.

EFSA's opinion adds animal data. In a 90-day rat study, effects on reproductive organs set the no-observed-adverse-effect level at 400 mg per kg of body weight a day. EFSA judged the margin to a 300 mg human dose (about 93-fold) sufficient, but it excluded pregnant and breastfeeding women. The 300 mg dose equals about 110 mg of nicotinamide, well under EFSA's upper limit of 900 mg a day for nicotinamide.

Many products sell 500 mg or 1,000 mg per serving. Those amounts were tolerated in trials of a few months, but they go beyond what EFSA assessed.

Is NMN legal? The FDA reversal

NMN's legal history explains a lot about the market. In late 2022 FDA told two ingredient makers, SyncoZymes and Inner Mongolia Kingdomway, that NMN could not be a dietary ingredient because it had first been investigated as a drug. The Natural Products Association and the Alliance for Natural Health petitioned FDA in 2023 and sued in 2024.

On 29 September 2025 FDA reversed course. According to the Natural Products Association and a National Law Review analysis, FDA accepted evidence that NMN was sold as a supplement in the US as early as 2017, before drug investigations, so it is not excluded. FDA sent confirming letters to both companies on 2 December 2025.

That makes NMN lawful in the US, but not approved: like all supplements, it is not reviewed by FDA for safety or effectiveness before sale. In the EU, NMN is a novel food and needs authorisation, which the European Commission has not yet granted.

Do NMN supplements contain NMN?

Often not in the amount stated. A 2024 study in GeroScience bought 18 NMN products online and in pharmacies and measured their content. Results ranged from 28.6% above the label to 100% below it, and three products contained no detectable NMN. The authors cited an earlier industry test, by ChromaDex (which sells a competing NAD+ precursor), that found 14 of 22 products had less than 1% of the claimed NMN.

A 2026 study in Analytica Chimica Acta tested eight products with a new method that separates the natural beta form of NMN from the alpha form. It found wide variation in isomer content, including undeclared or wrongly labelled ingredients.

For an expensive supplement bought mostly online, this is the main risk: paying for nothing, or for something other than what is on the label.

Who should be careful

• Pregnant and breastfeeding women: EFSA excluded them, and there are no data.
• People with cancer or a history of cancer: NAD+ is used by all cells, and NMN has not been studied in this group. Ask your oncologist.
• People already taking niacin, nicotinamide or nicotinamide riboside: the B3 doses add up.
• Children and teenagers: no data and no reason to use it.

If you have a long-term condition or take regular medicines, talk to your doctor or pharmacist before starting.

How to buy NMN more safely

1. Ask for a certificate of analysis from an independent lab that measures beta-NMN by HPLC, with a batch number matching your bottle.
2. Prefer 250 to 300 mg a day, the range with the most trial and EFSA support.
3. Avoid sellers with no traceable company address and products far cheaper than the market.
4. Stack carefully: if you take other anti-ageing supplements such as DHEA, each one has its own risks.

How we scored it

Organ toxicity (85) and interactions (85) are good: no liver signal in trials and no documented drug interactions. Dose safety (78) reflects short trials and the gap between EFSA's 300 mg and common doses. Product quality (40) is the weakest factor, with products holding none of the claimed NMN. Regulatory actions (62) reflect FDA's three-year exclusion and the missing EU authorisation.